Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/25/2022 | News release | Distributed by Public on 01/25/2022 03:03
Please select the service you want to use:
Smartlinks | Avalara Inc. | News | Technology | E-Commerce | Company News | Information Technology | Software | Retail | E-Commerce | Public Companies | Software Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Bolsa Mexicana de Valores (BMV) | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact